“Preclinical and clinical studies of the drug have demonstrated its high effectiveness and safety... The Russian Ministry of Health has issued a permanent registration certificate for the drug for medical use,” TASS reports.
In March 2023, the drug MIR 19 for coronavirus was approved for outpatient use.
The Federal Medical and Biological Agency of Russia (FMBA) has expressed its readiness to offer African countries the organization of joint production of medicines and vaccines on the African continent.